Views & Analysis | Perspectives on pharma industry issues

Market Access

Sponsored

Company Profile: Acumetis

Acumetis is a global expert commercialisation partner purposefully built to help life sciences companies win in the age of connectivity.

R&D

Changing Faces: Pharma and biotech hires, May 2026

Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.

R&D

pharmaphorum podcast Episode 266, Parexel - Paul Bridges and Charlotte Moser

Parexel: Flawless execution, policy shifts & patient-centric...

Parexel's Paul Bridges & Charlotte Moser discuss Europe's biotech sector in the face of an innovation cliff.

Sales & Marketing

Pharmacist reads doctor's notes with AI overlay concept in pharmacy

How pharma can make pharmacies a powerful marketing channel

Among POC marketing strategies, activating the pharmacy environment is especially powerful.

Oncology

ASCO 2026: Three ADC approvals in five days, with Ken Keller...

At ASCO 26, Daiichi Sankyo leaders Ken Keller and John Tsai chatted with pharmaphorum about their big year of oncology launches, halfway in.

R&D

Six things we learned about the obesity market at LSX 2025

In LSX's Obesity Science and Innovation forum, experts gave the inside scoop on the challenges and opportunities that remain in GLP-1s.

Patients

Frontiers Health limited series podcast, Roberta Sarno

FH25: On patient access and equity, with Roberta Sarno

In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with founder, director, and global health advisor.

R&D

The importance of understanding the differences between 503A...

Inside the ecosystem of compounding pharmacies, 503A and 503B facilities are distinct.

Sales & Marketing

How pharma can make pharmacies a powerful marketing channel

Among POC marketing strategies, activating the pharmacy environment is especially powerful.

Sales & Marketing

Sponsored

12 Questions with Shauna Lord

Shauna Lord recently joined GSK as Business Unit Head Specialty (UK Commercial) to lead the Specialty business in the UK.

Digital

How a Norwegian hospital unlocked capacity without adding st...

The question for healthcare leaders is less whether AI has a role in surgical planning, and more how to implement it best.

Digital

Integration: The key to scalable decentralised trials

Successful DCTs depend less on the technology deployed and more on how effectively those capabilities are integrated and executed.

Market Access

Sponsored

Company Profile: Acumetis

Acumetis is a global expert commercialisation partner purposefully built to help life sciences companies win in the age of connectivity.

Market Access

Why 70% of pharma partnership spend misses patients

Finding a start-up or building an app is the cheap part; combining capabilities into something that scales across markets is the expensive part.

Oncology

ASCO 2026: Three ADC approvals in five days, with Ken Keller...

At ASCO 26, Daiichi Sankyo leaders Ken Keller and John Tsai chatted with pharmaphorum about their big year of oncology launches, halfway in.

Oncology

ASCO 2026: Can a blood test spot cancer early? with Dr Peter...

Dr Peter Sasieni, co-investigator for the NHS Galleri trial, discusses advances in population-level blood screening for early cancer detection.

Oncology

CAR-T has a geography problem

The gap between what CAR-T can do and who can actually get it is the defining challenge of this field right now.

Patients

Sponsored

Designing global PSPs for the real world

How integrating strategic design with implementation expertise can help create more scalable, locally relevant, and effective global PSPs.

Patients

Is women’s health reaching an inflection point?

A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.

Patients

Patient engagement drives clinical and commercial success

Engagement solutions can tap into long-lasting patient motivations that sustain behaviour.

Company Profile: Acumetis

Changing Faces: Pharma and biotech hires, May 2026

Parexel: Flawless execution, policy shifts & patient-centric...

How pharma can make pharmacies a powerful marketing channel

ASCO 2026: Three ADC approvals in five days, with Ken Keller...

Six things we learned about the obesity market at LSX 2025

FH25: On patient access and equity, with Roberta Sarno

The importance of understanding the differences between 503A...

How pharma can make pharmacies a powerful marketing channel

12 Questions with Shauna Lord

How a Norwegian hospital unlocked capacity without adding st...

Integration: The key to scalable decentralised trials

Company Profile: Acumetis

Why 70% of pharma partnership spend misses patients

ASCO 2026: Three ADC approvals in five days, with Ken Keller...

ASCO 2026: Can a blood test spot cancer early? with Dr Peter...

CAR-T has a geography problem

Designing global PSPs for the real world

Is women’s health reaching an inflection point?

Patient engagement drives clinical and commercial success

Changing Faces: Pharma and biotech hires, May 2026

Parexel: Flawless execution, policy shifts & patient-centric...

Women in STEM: Overcoming exclusionary workplace culture

Anthropic launches Claude Science for pharma researchers

Discover a new era of healthcare panel engagement: Grounded ...

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks